US · Healthcare

JW (Cayman) Therapeutics Co. Ltd (JWCTF)

Biotechnology

JW (Cayman) Therapeutics Co. Ltd (JWCTF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for JWCTF

P/E ratio

25.00

JW (Cayman) Therapeutics Co. Ltd (JWCTF) — FAQ

What is JWCTF's P/E ratio?

The price-to-earnings (P/E) ratio for JW (Cayman) Therapeutics Co. Ltd (JWCTF) is 25.00 (data as of 2026-05-23).

Does JW (Cayman) Therapeutics Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for JW (Cayman) Therapeutics Co. Ltd (JWCTF). Check the MyAverix Finance app for the latest dividend data.

What sector is JW (Cayman) Therapeutics Co. Ltd in?

JW (Cayman) Therapeutics Co. Ltd (JWCTF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is JWCTF listed on?

JWCTF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)